In October 2022, Sanquin Reagents B.V. became independent, and will continue under a different name: Essange Reagents. Our services and product portfolio will remain unchanged, as will our current address at the Plesmanlaan 125 in Amsterdam.
Essange Reagents develops and produces reagents for blood grouping and specific plasma proteins (IgG subclasses, cytokines, CD monoclonals).
These reagents are for in vitro diagnostic (IVD) use or for research use only (RUO).
What do we do?
- We develop, produce and market reagents and kits
- We provide assay services
- We offer quality panels and surveys
- We developed and market PeliPIP software and tools
- We sell Magister C24
- Assist with business development
- We offer OEM (Original Equipment Manufacturer) assays and antibodies
for companies in the diagnostics industry so that they can benefit from
our expertises.
Company Details
- Employees
- 69
- Founded
- 2023
- Address
- Plesmanlaan 125, Amsterdam,north Holland 1066 Cx,netherlands
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Keywords
- Immune Reagents, IgG subclasses, Blood Grouping Reagents, CD monoclonals, Biologics, Magister C24, Granzymes, Monocyte activation test.
- HQ
- Amsterdam, North Holland
Essange Reagents Questions
Essange Reagents's LinkedIn profile is https://nl.linkedin.com/company/essangereagents
Essange Reagents has
69 employees.
View email and phone details for 69
employees at Essange Reagents.
Essange Reagents's industry is
Hospitals and Health Care
Essange Reagents's top competitors are
Health & Innovation District Amsterdam (Hid),
Sanquin,
Stichting Sanquin Bloedvoorziening,
Mrc Holland,
Onlyblue,
Vitestro,
Voicebooking.com,
Prothya Biosolutions,
Florence,
Bio-Connect Bv.
Essange Reagents's categories are Hospitals and Health Care
Essange Reagents's founding year is 2023
